-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JxybQDXvmcwQ0yBNB0cfRPljXWs9fCyKcqq7AopMEhjJdKuDA6X7VSBmzFef+LP8 cCEFoaUrl2wDfZ9ISIuAPA== 0000899140-08-001309.txt : 20080610 0000899140-08-001309.hdr.sgml : 20080610 20080610163921 ACCESSION NUMBER: 0000899140-08-001309 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20050201 FILED AS OF DATE: 20080610 DATE AS OF CHANGE: 20080610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCESS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 N STEMMONS FRWY STREET 2: STE 176 CITY: DALLAS STATE: TX ZIP: 75207 BUSINESS PHONE: 2149055100 MAIL ADDRESS: STREET 1: 2600 N STEMMONS FRWY STREET 2: STE 176 CITY: DALLAS STATE: TX ZIP: 75207 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX CORP/WY DATE OF NAME CHANGE: 19831102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORACLE INVESTMENT MANAGEMENT INC CENTRAL INDEX KEY: 0001012622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 08891181 BUSINESS ADDRESS: STREET 1: 200 GREENWICH AVE STREET 2: 3RD FL CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 2126886262 MAIL ADDRESS: STREET 1: 200 GREENWICH AVE STREET 2: 3RD FL CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORACLE INSTITUTIONAL PARTNERS L P CENTRAL INDEX KEY: 0000924141 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 08891182 BUSINESS ADDRESS: STREET 1: 712 FIFTH AVE STREET 2: 45TH FL CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORACLE PARTNERS LP CENTRAL INDEX KEY: 0000941901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 08891183 BUSINESS ADDRESS: STREET 1: 200 GREENWICH AVE STREET 2: 3RD FL CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 2126886262 MAIL ADDRESS: STREET 1: 200 GREENWICH AVE STREET 2: 3RD FL CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oracle Associates LLC CENTRAL INDEX KEY: 0001317217 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 08891184 BUSINESS ADDRESS: STREET 1: 200 GREENWICH AVENUE, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-862-1660 MAIL ADDRESS: STREET 1: 200 GREENWICH AVENUE, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FEINBERG LARRY N CENTRAL INDEX KEY: 0000926475 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 08891185 BUSINESS ADDRESS: STREET 1: C/O ORACLE PARTNERS L P STREET 2: 712 FIFTH AVENUE 45TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2038627900 MAIL ADDRESS: STREET 1: C/O ORACLE PARTNERS L P STREET 2: 200 GREENWICH AVENUE CITY: GREENWICH STATE: CT ZIP: 06830 4 1 feinberg_accp4-060208ex.xml X0202 4 2005-02-01 0 0000318306 ACCESS PHARMACEUTICALS INC ACCP 0000926475 FEINBERG LARRY N C/O ORACLE ASSOCIATES, LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830 0 0 1 0 0001317217 Oracle Associates LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830 0 0 1 0 0000941901 ORACLE PARTNERS LP C/O ORACLE ASSOCIATES, LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830 0 0 1 0 0000924141 ORACLE INSTITUTIONAL PARTNERS L P C/O ORACLE ASSOCIATES, LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830 0 0 1 0 0001012622 ORACLE INVESTMENT MANAGEMENT INC 200 GREENWICH AVE, 3RD FLOOR GREENWICH CT 06830 0 0 1 0 Common Stock, par value $0.01 per share ("Common Stock") 2005-02-01 4 P 0 30200 2.69 A 1242500 I See footnote Common Stock 2005-02-01 4 S 0 30200 2.69 D 1242500 I See footnote Common Stock 2005-12-31 4 P 0 15636 0.65 A 1718121 I See footnote Common Stock 2005-12-31 4 P 0 82745 0.65 A 1718121 I See footnote Common Stock 2005-12-31 4 P 0 299056 0.65 A 1718121 I See footnote Common Stock 2005-12-31 4 P 0 78184 0.65 A 1718121 I See footnote Common Stock 2006-06-05 4 J 0 1374497 D 343624 I See footnote Common Stock 2006-09-01 4 S 0 0.8 D 343623 I See footnote Common Stock 2006-09-01 4 S 0 0.2 D 343623 I See footnote Common Stock 2006-09-01 4 S 0 0.2 D 343623 I See footnote Common Stock 2007-01-22 4 S 0 6040 2.53 D 343623 I See footnote Common Stock 2007-01-22 4 P 0 6040 2.53 A 343623 I See footnote Common Stock 2007-02-26 4 S 0 19000 7.314 D 318623 I See footnote Common Stock 2007-02-26 4 S 0 5000 7.314 D 318623 I See footnote Common Stock 2007-02-26 4 S 0 1000 7.314 D 318623 I See footnote Common Stock 2007-02-27 4 S 0 300 7 D 318223 I See footnote Common Stock 2007-02-27 4 S 0 100 7 D 318223 I See footnote Common Stock 2007-02-28 4 S 0 10000 7.1 D 302523 I See footnote Common Stock 2007-02-28 4 S 0 4500 7.1 D 302523 I See footnote Common Stock 2007-03-01 4 S 0 1200 7.125 D 302523 I See footnote Common Stock 2007-06-19 4 S 0 40000 5.17 D 302523 I See footnote Common Stock 2007-06-19 4 S 0 20000 5.17 D 302523 I See footnote Common Stock 2007-06-19 4 P 0 60000 5.17 A 302523 I See footnote Common Stock 2007-07-23 4 S 0 4000 4.3563 D 298523 I See footnote Common Stock 2007-07-24 4 S 0 2040 4.35 D 296483 I See footnote Common Stock 2008-02-12 4 P 0 29736 3.15 A 296483 I See footnote Common Stock 2008-02-12 4 S 0 29736 3.15 D 296483 I See footnote Series A Cumulative Convertible Preferred Stock 2007-11-10 4 J 0 437 A Common Stock 1457707 437 I See footnote Common Stock Purchase Warrants 2007-11-10 4 J 0 728850 A Common Stock 728850 728850 I See footnote Series A Cumulative Convertible Preferred Stock 2008-03-11 4 P 0 72 A Common Stock 240000 72 I See footnote Series A Cumulative Convertible Preferred Stock 2008-03-11 4 S 0 72 A Common Stock 240000 72 I See footnote Common Stock Purchase Warrants 2008-03-11 4 P 0 119811 A Common Stock 119811 119811 I See footnote Common Stock Purchase Warrants 2008-03-11 4 S 0 119811 A Common Stock 119811 119811 I See footnote See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. See Exhibit 99.1. (10) - (15) See Exhibit 99.1. Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information for Oracle Associates Exhibit 99.3 - Joint Filer Information for Oracle Partners Exhibit 99.4 - Joint Filer Information for Oracle Institutional Partners Exhibit 99.5 - Joint Filer Information for Oracle Investment Management /s/ Larry N. Feinberg 2008-06-10 EX-99 2 f4130448a.txt EXHIBIT 99.1 EXPLANATION OF RESPONSES Exhibit 99.1 Explanation of Responses (1) Mr. Larry N. Feinberg ("Mr. Feinberg") serves as: (i) managing member of Oracle Associates, LLC ("Oracle Associates"), which is general partner of Oracle Partners, L.P. ("Oracle Partners"), Oracle Institutional, L.P. ("Oracle Institutional") and certain other investment funds and accounts (collectively, the "Domestic Funds"); (ii) sole shareholder and president of Oracle Investment Management, Inc., a Delaware corporation ("Oracle Investment Management"), which serves as investment manager to and has investment discretion over the securities held by (a) SAM Oracle Investments Inc. ("SAM Oracle"), (b) Oracle Offshore Limited, a Cayman Islands corporation (together with SAM Oracle a certain other funds, the "Foreign Funds") and (c) Oracle Management, Inc. Employees Retirement Plan, ("Oracle 401K" together with the Foreign Funds, the "Managed Funds" and, together with the Domestic Funds, the "Funds") and (iii) trustee of The Feinberg Family Foundation (the "Foundation"). The shares of common stock, par value $0.01 per share (the "Common Stock"), of Access Pharmaceuticals, Inc. (the "Company"), Series A Cumulative Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock"), of the Company and the Common Stock Purchase Warrants (the "Warrants") to which this Form 4 pertains are held directly by the Funds and the Foundation, which Mr. Feinberg may be deemed to beneficially own by virtue of the foregoing relationships. In accordance with instruction 4(b)(v), the entire number of shares of Common Stock, Preferred Stock and Warrants that may be deemed to be beneficially owned by Mr. Feinberg by virtue of such relationships is reported herein. Mr. Feinberg disclaims any beneficial ownership of the securities held by the Funds and the Foundation for purposes of Section 16 of the Securities Exchange Act of 1934, except to the extent of Mr. Feinberg's pecuniary interest. (2) As of the date hereof, Mr. Feinberg beneficially owns 2,483,040 shares, consisting of 296,483 shares of Common Stock (3,660 shares of which are held directly by the Foundation), 1,457,707 shares of Common Stock that would be received upon the conversion of 437 shares of Preferred Stock, and 728,850 shares of that would be received on exercise of the Warrants. (3) Mr. Feinberg serves as trustee of Foundation which holds 3,660 shares of Common Stock directly. Mr. Feinberg may be deemed to beneficially own such shares by virtue of his position as trustee and such shares are included in Mr. Feinberg's total beneficial ownership indicated in note (2) above. (4) On June 6, 2005, the Company effected a five-to-one reverse stock split of its Common Stock. The disposition of shares to which this note relates does not represent a sale of beneficial ownership. It represents solely an adjustment due to such stock split. (5) This transaction involved an administrative adjustment for accounting purposes only. (6) Each share of Preferred Stock is convertible in whole or in part, at any time or from time to time, at the option of the holder into 3,333.33 shares of Common Stock, at an exercise price of $3.00, subject to adjustment. (7) A series of transactions involving the Company were described in the Company's Current Report on Form 8-K, filed on November 14, 2007. In connection with these transactions, existing convertible notes held by the Funds having an aggregate value of $4,373,104.54 (principal amount of $4,015,000 plus interest accrued thereon of $358,104.54), were exchanged into 437 shares of Preferred Stock and Warrants to purchase 728,850 shares of Common Stock. (8) The transactions to which this note relates involve a transfer of Preferred Stock and Warrants held by SAM Oracle to Oracle Institutional in connection with the liquidation of the portfolio of SAM Oracle. The transferred Preferred Stock was at such time valued at $495,720 and no value was accorded to the transferred Warrants. (9) The Warrants are exercisable in whole or in part, at any time or from time to time (beginning on November 10, 2007), at the option of the holder until November 10, 2013, at an exercise price of $3.50 per share, subject to adjustment. (10) Oracle Associates is general partner of the Domestic Funds. The shares of Common Stock, Preferred Stock and Warrants to which this note pertains are held directly by the Domestic Funds, which Oracle Associates may be deemed to beneficially own by virtue of the foregoing relationship. In accordance with instruction 4(b)(v), the entire number of shares of Common Stock, Preferred Stock and Warrants that may be deemed to be beneficially owned by Oracle Associates by virtue of such relationships is reported herein. Oracle Associates disclaims any beneficial ownership of the securities held by the Domestic Funds for purposes of Section 16 of the Securities Exchange Act of 1934, except to the extent of Oracle Associates' pecuniary interest. (11) As of the date hereof, Oracle Associates beneficially owns 2,402,486 shares, consisting of 287,816 shares of Common Stock, 1,409,782 shares of Common Stock that would be received upon the conversion of 423 shares of Preferred Stock, and 704,888 shares that would be received upon the exercise of Warrants. (12) As of the date hereof, Oracle Partners beneficially owns 1,622,488 shares, consisting of 247,651 shares of Common Stock, 916,560 shares of Common Stock that would be received upon the conversion of 275 shares of Preferred Stock and 458,277 shares that would be received upon exercise of Warrants. (13) Oracle Investment Management ("Investment Manager") serves as investment manager to and has investment discretion over the securities held by the Managed Funds. The shares of Common Stock, Preferred Stock and Warrants to which this note pertains are held directly by the Managed Funds, which the Investment Manager may be deemed to beneficially own by virtue of the foregoing relationship. In accordance with instruction 4(b)(v), the entire number of shares of Common Stock, Preferred Stock and Warrants that may be deemed to be beneficially owned by the Investment Manager by virtue of such relationship is reported herein. The Investment Manager disclaims any beneficial ownership of the securities held by the Managed Funds for purposes of Section 16 of the Securities Exchange Act of 1934, except to the extent of the Investment Manager's pecuniary interest. (14) As of the date hereof, Oracle Investment Management beneficially owns 76,893 shares consisting of 5007 shares of Common Stock, 47,924 shares of Common Stock that would be received upon the conversion of 14 shares of Preferred Stock and 23,962 shares that would be received upon exercise of Warrants. (15) As of the date hereof, Oracle Institutional beneficially owns 779,998 shares consisting of 40,165 shares of Common Stock, 493,222 shares of Common Stock that would be received upon the conversion of 148 shares of Preferred Stock and 246,611 shares that would be received upon exercise of Warrants. EX-99 3 f4130448b.txt EXHIBIT 99.2 JOINT FILER INFO FOR ORACLE ASSOCIATES Exhibit 99.2 FORM 4 JOINT FILER INFORMATION (Attachment to Form 4 in accordance with instruction 4(b)(v)) Check this box if no longer subject to Section 16: [ ] Name and Address: Oracle Associates, LLC 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830 Issuer and Ticker Symbol: Access Pharmaceuticals, Inc. ("ACCP") Date of Earliest Transaction: 12/31/05 Relationship to Issuer: 10% Owner Designated Filer: Larry N. Feinberg TABLE I INFORMATION Title of Security: Common Stock Transaction Date: 12/31/2005 Transaction Code: P Securities Disposed: 299,056 Acquired or Disposed: A Price: $0.65 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 12/31/2005 Transaction Code: P Securities Disposed: 82,745 Acquired or Disposed: A Price: $0.65 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 6/5/2006 Transaction Code: (J) (4) Securities Disposed: 14,104,032 Acquired or Disposed: D Price: $0.00 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 6/5/2006 Transaction Code: (J) (4) Securities Disposed: 222,116 Acquired or Disposed: D Price: $0.00 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 9/1/2006 Transaction Code: J Securities Disposed: 0.2 Acquired or Disposed: D Price: $0.00 (5) Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 1/22/2007 Transaction Code: P Securities Disposed: 6,040 Acquired or Disposed: A Price: $2.53 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 2/26/2007 Transaction Code: S Securities Disposed: 19,000 Acquired or Disposed: D Price: $7.314 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 2/26/2007 Transaction Code: S Securities Disposed: 5,000 Acquired or Disposed: D Price: $7.314 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 2/27/2007 Transaction Code: S Securities Disposed: 300 Acquired or Disposed: D Price: $7.00 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 2/27/2007 Transaction Code: S Securities Disposed: 100 Acquired or Disposed: D Price: $7.00 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 6/19/2007 Transaction Code: S Securities Disposed: 40,000 Acquired or Disposed: D Price: $5.17 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 6/19/2007 Transaction Code: P Securities Disposed: 60,000 Acquired or Disposed: A Price: $5.17 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) Title of Security: Common Stock Transaction Date: 2/12/2008 Transaction Code: P Securities Disposed: 29,736 Acquired or Disposed: A Price: $3.15 Ownership Form: I Amount Beneficially Owned After Transaction (11) Nature of Indirect Beneficial Ownership (10) TABLE II INFORMATION Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 11/10/07 Transaction Code: J (7) Securities Acquired: 351 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 1,170,150 Price of Derivative Securities: (7) Number Beneficially Owned 351 Ownership Form: I Nature of Indirect Beneficial Ownership (10) Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 11/10/07 Transaction Code: J (7) Securities Acquired: 585,077 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 585,077 Price of Derivative Securities: (7) Number Beneficially Owned 585,077 Ownership Form: I Nature of Indirect Beneficial Ownership (10) Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 3/11/08 Transaction Code: P Securities Acquired: 72 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 240,000 Price of Derivative Securities: (8) Number Beneficially Owned 423 Ownership Form: I Nature of Indirect Beneficial Ownership (10) Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 3/11/08 Transaction Code: P Securities Acquired: 119,811 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 119,811 Price of Derivative Securities: (8) Number Beneficially Owned 119,811 Ownership Form: I Nature of Indirect Beneficial Ownership (10) Explanation of Responses: (4) - (11): See Exhibit 99.1. Signature: ORACLE ASSOCIATES, LLC By: /s/ Larry N. Feinberg ---------------------------------- Name: Larry N. Feinberg Title: Managing Member Date: June 10, 2008 EX-99 4 f4130448c.txt EXHIBIT 99.3 JOINT FILER INFO FOR ORACLE PARTNERS Exhibit 99.3 FORM 4 JOINT FILER INFORMATION (Attachment to Form 4 in accordance with instruction 4(b)(v)) Check this box if no longer subject to Section 16: [ ] Name and Address: Oracle Partners, L.P. c/o Oracle Associates, LLC 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830 Issuer and Ticker Symbol: Access Pharmaceuticals, Inc. ("ACCP") Date of Earliest Transaction: 12/31/05 Relationship to Issuer: 10% Owner Designated Filer: Larry N. Feinberg TABLE I INFORMATION Title of Security: Common Stock Transaction Date: 12/31/2005 Transaction Code: P Securities Disposed: 299,056 Acquired or Disposed: A Price: $0.65 Ownership Form: D Amount Beneficially Owned After Transaction (12) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 6/5/2006 Transaction Code: (J) (4) Securities Disposed: 14,104,032 Acquired or Disposed: D Price: $0.00 Ownership Form: D Amount Beneficially Owned After Transaction (12) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 9/1/2006 Transaction Code: S Securities Disposed: 0.2 (5) Acquired or Disposed: D Price: $0.00 Ownership Form: D Amount Beneficially Owned After Transaction (12) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 1/22/2007 Transaction Code: P Securities Disposed: 6,040 Acquired or Disposed: A Price: $2.53 Ownership Form: D Amount Beneficially Owned After Transaction (12) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/26/2007 Transaction Code: S Securities Disposed: 19,000 Acquired or Disposed: D Price: $7.314 Ownership Form: D Amount Beneficially Owned After Transaction (12) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/27/2007 Transaction Code: S Securities Disposed: 300 Acquired or Disposed: D Price: $7.00 Ownership Form: D Amount Beneficially Owned After Transaction (12) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 6/19/2007 Transaction Code: P Securities Disposed: 60,000 Acquired or Disposed: A Price: $5.17 Ownership Form: D Amount Beneficially Owned After Transaction (12) Nature of Indirect Beneficial Ownership TABLE II INFORMATION Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 11/10/07 Transaction Code: J (7) Securities Acquired: 275 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 916,552 Price of Derivative Securities: (7) Number Beneficially Owned 275 Ownership Form: D Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (6) Transaction Date: 11/10/07 Transaction Code: J (7) Securities Acquired: 458,277 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 458,277 Price of Derivative Securities: (7) Number Beneficially Owned 458,277 Ownership Form: D Explanation of Responses: (4) - (7), (9) and (12): See Exhibit 99.1. Signature: ORACLE PARTNERS, L.P. By: Oracle Associates, LLC, its General Partner By: /s/ Larry N. Feinberg --------------------------------- Name: Larry N. Feinberg Title: Managing Member Date: June 10, 2008 EX-99 5 f4130448d.txt EXHIBIT 99.4 JOINT FILER INFO FOR ORACLE INSTITUTIONAL PARTNERS Exhibit 99.4 FORM 4 JOINT FILER INFORMATION (Attachment to Form 4 in accordance with instruction 4(b)(v)) Check this box if no longer subject to Section 16: [ ] Name and Address: Oracle Institutional Partners, L.P. c/o Oracle Associates, LLC 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830 Issuer and Ticker Symbol: Access Pharmaceuticals, Inc. ("ACCP") Date of Earliest Transaction: 12/31/2005 Relationship to Issuer: 10% Owner Designated Filer: Larry N. Feinberg TABLE I INFORMATION Title of Security: Common Stock Transaction Date: 12/31/2005 Transaction Code: P Securities Disposed: 82,745 Acquired or Disposed: A Price: $0.65 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 6/5/2006 Transaction Code: (J) (4) Securities Disposed: 222,116 Acquired or Disposed: D Price: $0.00 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/26/2007 Transaction Code: S Securities Disposed: 5,000 Acquired or Disposed: D Price: $7.314 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/27/2007 Transaction Code: S Securities Disposed: 100 Acquired or Disposed: D Price: $7.00 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 6/19/2007 Transaction Code: P Securities Disposed: 40,000 Acquired or Disposed: A Price: $5.17 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership Title of Security: Common Stock Transaction Date: 2/12/2008 Transaction Code: P Securities Disposed: 29,736 Acquired or Disposed: A Price: $3.15 Ownership Form: D Amount Beneficially Owned After Transaction (15) Nature of Indirect Beneficial Ownership TABLE II INFORMATION Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 11/10/07 Transaction Code: J Securities Acquired: 76 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 253,600 Price of Derivative Securities: (7) Number Beneficially Owned 76 Ownership Form: D Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 11/10/07 Transaction Code: P Securities Acquired: 126,800 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 126,800 Price of Derivative Securities: (7) Number Beneficially Owned 126,800 Ownership Form: D Nature of Indirect Beneficial Ownership Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 3/11/08 (7) Transaction Code: P Securities Acquired: 72 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 240,000 Price of Derivative Securities: (8) Number Beneficially Owned 148 Ownership Form: D Nature of Indirect Beneficial Ownership Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 3/11/08 (7) Transaction Code: P Securities Acquired: 119,811 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 119,811 Price of Derivative Securities: (8) Number Beneficially Owned 246,611 Ownership Form: D Nature of Indirect Beneficial Ownership Explanation of Responses: (4), (6) - (9), (12), and (15) See Exhibit 99.1. Signature: ORACLE INSTITUTIONAL PARTNERS, L.P. By: Oracle Associates, LLC, its General Partner By: /s/ Larry N. Feinberg --------------------------------- Name: Larry N. Feinberg Title: Managing Member Date: June 10, 2008 EX-99 6 f4130448e.txt EXHIBIT 99.5 JOINT FILER INFORMATION FOR ORACLE INVESTMENT MANAGEMENT Exhibit 99.5 FORM 4 JOINT FILER INFORMATION (Attachment to Form 4 in accordance with instruction 4(b)(v)) Check this box if no longer subject to Section 16: [ X ] Name and Address: Oracle Investment Management, Inc. 200 Greenwich Avenue, 3rd Floor Greenwich, CT 06830 Issuer and Ticker Symbol: Access Pharmaceuticals, Inc. ("ACCP") Date of Earliest Transaction: 2/12/08 Relationship to Issuer: 10% Owner Designated Filer: Larry N. Feinberg TABLE I INFORMATION Title of Security: Common Stock Transaction Date: 2/12/2008 Transaction Code: S Securities Disposed: 29,736 Acquired or Disposed: D Price: $3.15 Ownership Form: I Amount Beneficially Owned After Transaction (14) Nature of Indirect Beneficial Ownership (13) TABLE II INFORMATION Title of Derivative Security: Preferred Stock Conversion or Exercise Price of Derivative Security (6) Transaction Date: 11/10/2007 Transaction Code: S (7) Securities Acquired: 86 Date Exercisable and Expiration Date: (6) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 240,000 Price of Derivative Securities: $6,885.00 Number Beneficially Owned 86 Ownership Form: I Nature of Indirect Beneficial Ownership (13) Title of Derivative Security: Warrants Conversion or Exercise Price of Derivative Security (9) Transaction Date: 11/10/2007 Transaction Code: S Securities Acquired: 143,773 Date Exercisable and Expiration Date: (9) Title of Underlying Securities: Common Stock Amount of Underlying Securities: 143,773 Price of Derivative Securities: (7) Number Beneficially Owned 143,773 Ownership Form: I Nature of Indirect Beneficial Ownership (13) Explanation of Responses: (6), (7), (9), (13) and (14): See Exhibit 99.1. Signature: ORACLE INVESTMENT MANAGEMENT, INC. By: /s/ Larry N. Feinberg --------------------------------- Name: Larry N. Feinberg Title: President Date: June 10, 2008 -----END PRIVACY-ENHANCED MESSAGE-----